ABILITY PHARMA
Live / Applied — Final refusal mailed (as of 19 Nov 2025)
What this means for you
Not registered yet, but its 30 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79416504
- Mark type
- Stylized text
- Filed
- 30 Sept 2024
- Attorney of record
- Melissa Dangond
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
- Class 042 — Scientific and technological services: Scientific and technological research activities for development of new drugs and medicines; Technical consultancy in the field of pharmaceutical studies, in particular relating to evaluations, estimates, and reports prepared in the course of scientific and technological research in the field of pharmaceutical medicines; Industrial analysis, namely, analysis of pharmacokinetics, pharmacodynamics and biomarkers related to drugs and medicines or pathologies to assure compliance with industry standards; Industrial research in the field of medicine
Owner
Prosecution history
- 12 Feb 2026 — LIMITATION OF GOODS RECEIVED FROM IB
- 01 Jan 2026 — LIMITATION OF GOODS RECEIVED FROM IB
- 19 Nov 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 19 Nov 2025 — FINAL REFUSAL E-MAILED
- 19 Nov 2025 — FINAL REFUSAL WRITTEN
- 22 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Jun 2025 — REFUSAL PROCESSED BY IB
- 17 May 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 16 May 2025 — REFUSAL PROCESSED BY MPU
- 25 Mar 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 24 Mar 2025 — NON-FINAL ACTION WRITTEN
- 19 Mar 2025 — ASSIGNED TO EXAMINER
- 21 Feb 2025 — APPLICATION FILING RECEIPT MAILED